PharmaCielo Shifts Fiscal Year-End and Names New Auditor
Company Announcements

PharmaCielo Shifts Fiscal Year-End and Names New Auditor

Story Highlights

PharmaCielo (TSE:PCLO) has released an update.

PharmaCielo, a Canadian-based global medical cannabis company, has announced a change in its financial year-end to align with industry peers and appointed Davidson & Company LLP as its new auditor. The company’s financial year will now end on March 31, with a transitional report covering a fifteen-month period to be released, while Davidson’s regional experience is expected to enhance audit oversight.

For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPharmaCielo Extends Warrant Expiry to Boost Market Position
TipRanks Canadian Auto-Generated NewsdeskPharmaCielo’s Financial Health Improves in Q2 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App